CompletedInterventionalNot ApplicableUpdated May 11, 2017
Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction | NCT02925026 | Trialant
CompletedInterventionalNot ApplicableUpdated May 2, 2018
Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction
ClinicalTrials.gov ID
NCT02925026
Lead Sponsor
Washington University School of MedicineOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
235Actual
Last Update Posted
May 2, 2018Actual
Start Date
Oct 2016
Primary Completion Date
Dec 2017Actual
Completion Date
Dec 2017Actual
Brief Summary
Randomized, double-blind, placebo controlled trial of daily lactoferrin and lysozyme supplementation in improving environmental enteric dysfunction in Malawian children
Environmental Enteric Dysfunction
Lactoferrin
Lysozyme
Placebo
Ages Eligible for Study
Child (0-17)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
children aged 12-35 months
youngest eligible child in each household
Exclusion Criteria:
severe or moderate acute malnutrition
severe chronic illness
children unable to drink 20 mL of dual sugar solution
children in need of acute medical treatment for illness or injury at time of enrollment